Sanofi ‘Strongly Disagrees’ With EMA Rejection Of NAS Status For Nexviadyme

 
• By Neena Brizmohun
  
Doctors and medical researchers on conference meeting, discussing possible solutions for resolving a world health crisis.
Sanofi says the CHMP's rejection of NAS status fails to recognize and reward innovation • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Europe

More from Geography